RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies, and the therapeutic outcome remains undesirable due to its recurrence and metastasis. Gene dysregulation plays a pivotal role in the occurrence and progression of cancer, and the molecular mechanisms are largely unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Benchen, Li, Jianhao, Ren, Tong, Yang, Jing, Zhang, Guizhen, Liu, Liwen, Wang, Haiyu, Huang, Maoxin, Ren, Zhigang, Yu, Zujiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327752/
https://www.ncbi.nlm.nih.gov/pubmed/34350180
http://dx.doi.org/10.3389/fcell.2021.686547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327752/
https://www.ncbi.nlm.nih.gov/pubmed/34350180
http://dx.doi.org/10.3389/fcell.2021.686547

Ejemplares similares